Divya Pathak

Divya Pathak

Auto-generated profile, based on publicly available information

Divya Pathak

Gladstone Institute of Neurological Disease, San Francisco, CA 94158

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in FEMS Microbiology Letters
Verified
Journal Article
Open access
PDF file
SCSoumitesh Chakravorty
Soumitesh Chakravorty
DPDivya Pathak
Divya Pathak
MDMridu Dudeja
Mridu Dudeja
SHSagarika Haldar
Sagarika Haldar
MHM. Hanif
M. Hanif
JTJaya Sivaswami Tyagi
Jaya Sivaswami Tyagi
This study was designed to assess the vital issue of gene target length and PCR assay performance in relation to the detection of Mycobacterium tuber

1 March 2017 in eneuro
Verified
Journal Article
Open access
PDF file
DPDivya Pathak
Divya Pathak
ABAmandine Berthet
Amandine Berthet
JBJacob T. Bendor
Jacob T. Bendor
KYKatharine Yu
Katharine Yu
RSRhyomi C. Sellnow
Rhyomi C. Sellnow
KNKen Nakamura
Ken Nakamura
Increased α-synuclein (αsyn) and mitochondrial dysfunction play central roles in the pathogenesis of Parkinson’s disease (PD), and lowering αsyn is under intensive investigation as a therapeutic strategy for PD. Increased αsyn levels disrupt mitochondria and impair respiration, while reduced αsyn protects against mitochondrial toxins, suggesting that interactions between αsyn and mitochondria influences the pathologic and physiologic functions of αsyn. However, we do not know if αsyn affects normal mitochondrial function or if lowering αsyn levels impacts bioenergetic function, especially at the nerve terminal where αsyn is enriched. To determine if αsyn is required for normal mitochondrial function in neurons, we comprehensively evaluated how lowering αsyn affects mitochondrial function. We found that αsyn knockout (KO) does not affect the respiration of cultured hippocampal neurons or cortical and dopaminergic synaptosomes, and that neither loss of αsyn nor all three (α, β and γ) syn isoforms decreased mitochondria-derived ATP levels at the synapse. Similarly, neither αsyn KO nor knockdown altered the capacity of synaptic mitochondria to meet the energy requirements of synaptic vesicle cycling or influenced the localization of mitochondria to dopamine (DA) synapsesin vivo. Finally, αsyn KO did not affect overall energy metabolism in mice assessed with a Comprehensive Lab Animal Monitoring System. These studies suggest either that αsyn has little or no significant physiological effect on mitochondrial bioenergetic function, or that any such functions are fully compensated for when lost. These results implicate that αsyn levels can be reduced in neurons without impairing (or improving) mitochondrial bioenergetics or distribution.